You just read:

Ascentage Pharma to Present New Data at 2019 ASCO Annual Meeting from Clinical Trials of MDM2-p53 Antagonist and IAP Inhibitor in Cancers

News provided by

Ascentage Pharma

May 22, 2019, 19:00 ET